Why We're Different

Every peptide education resource you've encountered online has something in common: they're funded by selling the compounds they're educating you about.

“We don't sell peptides. We don't sell access to peptides. We sell clarity.”

PeptideClarity is the only vendor-independent consumer guide to the peptide economy. We translate clinical research into plain language, rate the evidence honestly, evaluate providers using published criteria and connect you to vetted options — with full transparency about how we evaluate them and how we make money.

The Information Landscape You're Navigating

Layer 1 — Vendor-Funded Education

Sites like research peptide vendors publish detailed guides, but they sell research peptides. Their educational content drives product sales. Even when the information is accurate, the incentive structure means they will never tell you “you probably don't need this peptide.”

Layer 2 — Telehealth-Attached Content

Telehealth platforms produce blogs and videos to drive consultations. Some content is genuinely helpful. But every piece funnels toward a booking page, and the evidence is framed to support the compounds that platform prescribes.

Layer 3 — Fragmented Independent Coverage

Independent newsletters, podcasts and YouTube channels occasionally cover peptides. Some coverage is excellent. But nobody has built a systematic, dedicated consumer platform without a product to sell.

That gap — the absence of a dedicated, independent, consumer-first peptide resource — is why PeptideClarity exists.

How We Make Money (Full Disclosure)

Revenue SourceHow It WorksOur Safeguard
Provider ReferralsWhen we recommend a provider and you book through our link, the provider pays us a referral fee.Referral fees never influence rankings. Our evaluation methodology is published.
Amazon AssociatesWe link to injection supplies (syringes, bacteriostatic water, sharps containers).We only link to commodity supplies, never to peptide products.
Lab Testing ReferralsWe recommend baseline labs before starting any peptide protocol and link to testing services.Lab recommendations are the same regardless of which service you use.
Newsletter Sponsorships (future)Brands in health and wellness can sponsor newsletter editions. Clearly labeled.We never accept sponsorship from peptide vendors or telehealth companies in our comparison tools.

That's it. No hidden revenue. No undisclosed relationships. If we ever add a revenue source, we'll tell you about it here.

Our Evidence Framework

T1: Strong Evidence

FDA-approved for at least one indication, or completed large-scale human RCTs.

Examples: Semaglutide

T2: Emerging Evidence

Compelling animal or small human studies, growing clinical use, limited large-scale human RCTs.

Examples: BPC-157, CJC-1295/Ipamorelin, TB-500, Semax, Thymosin Alpha-1

T3: Early / Anecdotal

Primarily preclinical data, case reports or community-reported outcomes.

Examples: Dihexa, PE-22-28

Every compound profile on PeptideClarity carries its evidence tier prominently. We show our work.

What We Don't Do

  • We don’t provide medical advice. We provide education and navigation tools.
  • We don’t prescribe anything. We’re not a telehealth platform.
  • We don’t accept payment from providers to influence rankings.
  • We don’t hide the limits of the evidence. When the data is thin, we say so.

“The peptide information market is full. The peptide trust market is empty. That's our opening — and yours.”

Last updated: April 2026